Novo Nordisk | Ativo Circulante



Current Assets Alterar Data
ANI Pharmaceuticals USD 536.29M 8.61M 2025-03
Aurora Cannabis CAD 494.21M 76.54M 2024-12
Bausch Health Companies USD 6.51B 782M 2025-06
Bristol-Myers Squibb USD 33.22B 2.44B 2025-06
Canopy Growth CAD 341.08M 50.58M 2024-12
Corcept Therapeutics USD 443.11M 4.61M 2025-06
Drreddys Laboratories INR 253.02B 4.89B 2024-12
Eli Lilly USD 41.26B 8.52B 2025-03
GlaxoSmithKline GBP 17.67B 412M 2025-06
Merck USD 35.5B 3.28B 2025-03
Novartis USD 25.94B 831M 2025-06
Novo Nordisk 174.4B 20.76B 2025-03
Novo Nordisk DKK 174.4B 20.76B 2025-03
Pacira USD 759.96M 14.83M 2025-03
Perrigo USD 2.53B 51.1M 2025-03
Prestige Brands USD 448.33M 71.16M 2025-03
Sanofi 37.02B 7B 2025-06
Supernus Pharmaceuticals USD 686.07M 46.07M 2024-12
Zoetis USD 5.88B 109M 2025-03


Novo Nordisk Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.